APA (7th ed.) Citation

R, N., EC, F., L, M., J, G., A, N., & TJ, O. (2026). A Phase 1, Open-Label, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ES-481 After Oral Administration in Healthy Volunteers. European journal of drug metabolism and pharmacokinetics, 51(1), 97. https://doi.org/10.1007/s13318-025-00979-8

Chicago Style (17th ed.) Citation

R, Niecestro, Foster EC, Millist L, Germaine J, Niecestro A, and O'Brien TJ. "A Phase 1, Open-Label, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ES-481 After Oral Administration in Healthy Volunteers." European Journal of Drug Metabolism and Pharmacokinetics 51, no. 1 (2026): 97. https://doi.org/10.1007/s13318-025-00979-8.

MLA (9th ed.) Citation

R, Niecestro, et al. "A Phase 1, Open-Label, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ES-481 After Oral Administration in Healthy Volunteers." European Journal of Drug Metabolism and Pharmacokinetics, vol. 51, no. 1, 2026, p. 97, https://doi.org/10.1007/s13318-025-00979-8.